Viewing nowCombinationTwin Heat Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kibbs Biopharma Co., Ltd.

MFDS item code 201605772 · Approved 2016.09.30 · Insurance code 693201750
Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy
This medicine is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: As the safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This medication is prohibited or requires caution in patients with certain diseases or conditions. For example, individuals with an allergy to any component of this medication, obstructive biliary disease, severe liver impairment, severe hypotension, cardiogenic shock, or unstable heart failure after acute myocardial infarction should not take this medication. Furthermore, women who may become pregnant and nursing mothers should not use this medication. Patients with primary aldosteronism, heart valve problems, liver disease, gastrointestinal diseases, renovascular hypertension, dialysis patients, and the elderly should use this medication cautiously. Since this medication lowers blood pressure, side effects such as dizziness and peripheral edema may commonly occur. In severe cases, syncope or cardiac adverse reactions might rarely occur, so caution is needed. It is important to regularly check blood pressure, kidney function, and electrolyte levels while taking this medication. In particular, due to the risk of hyperkalemia, potassium levels should be carefully monitored. This medication may interact with other drugs, so patients must consult with their doctor or pharmacist about any medications they are taking. Special caution is necessary when used concurrently with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, etc. Additionally, it is advisable to avoid taking this medication with grapefruit juice as it may increase the effect of the drug. This medication is not recommended for children, and elderly patients require dosage adjustment and caution. In case of overdose, hypotension and cardiac issues may occur, so medical assistance should be sought immediately. This medication should be stored out of reach of children, and should be taken immediately after opening the packaging.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in an airtight container that protects it from light. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain the efficacy of the drug.
A biconvex, oval-shaped double-coated tablet in white and light gray
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kibbs Biopharma Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.